Compare INO & HOVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INO | HOVR |
|---|---|---|
| Founded | 1979 | 2013 |
| Country | United States | Canada |
| Employees | N/A | 30 |
| Industry | Medical/Dental Instruments | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 80.6M |
| IPO Year | 1999 | N/A |
| Metric | INO | HOVR |
|---|---|---|
| Price | $1.10 | $1.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $6.75 | ★ $10.33 |
| AVG Volume (30 Days) | ★ 1.5M | 997.1K |
| Earning Date | 05-08-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,220,086.00 | N/A |
| Revenue This Year | $20,156.19 | N/A |
| Revenue Next Year | $421.95 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.03 | $1.16 |
| 52 Week High | $2.86 | $4.18 |
| Indicator | INO | HOVR |
|---|---|---|
| Relative Strength Index (RSI) | 40.11 | 52.95 |
| Support Level | $1.03 | $1.72 |
| Resistance Level | $1.24 | $2.00 |
| Average True Range (ATR) | 0.06 | 0.16 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 14.29 | 77.86 |
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.